MDClone is a healthcare company that is dedicated to transforming raw data into actionable insights that have a real impact on the healthcare industry. By providing self-service analytics, MDClone aims to remove traditional barriers to data access, allowing operational, clinical, and research teams to explore and utilize healthcare information quickly and confidently.
Ziv Ofek, the CEO and co-founder of MDClone, will be present at HIMSS25, showcasing perspectives from esteemed institutions such as the University of Chicago, Intermountain Health, McGill University, and Sheba Medical Center. One of the sessions at HIMSS25, titled “BEYOND Boundaries: Implementation of Telemedicine BEYOND Conventional Care Models,” will feature Ofek alongside Dr. Galia Barkai, Dr. Ronen Loebstein, and Liat Toderis, RN, from Sheba Medical Center in Israel.
The focus of the session will be on maximizing resource efficiency and improving patient outcomes through innovative care models. Sheba Medical Center’s groundbreaking work in high-risk pregnancies, providing personalized care at home to reduce patient stress, improve outcomes, and optimize hospital resources, will be highlighted as a success story in telehealth innovation.
At the HIMSS25 Exhibit Hall, MDClone’s message is clear: data should work for healthcare organizations, not against them. By showcasing real-world success stories from leading health systems that have overcome data silos, slow processes, and limited access to accelerate research, enhance clinical quality, and improve operational performance, MDClone aims to inspire others to leverage data effectively.
In the ever-evolving landscape of healthcare technology, Ofek emphasizes the importance of AI and data in driving improvements in patient outcomes, cost reduction, and operational efficiency. Technologies that empower clinicians and researchers to analyze complex clinical data independently and collaboratively are essential for making informed decisions that drive tangible results across quality, operations, and research.
For CIOs and IT leaders attending HIMSS25, Ofek advises focusing on people and processes in addition to technology. Adoption, change management, and governance are crucial considerations for successful technology implementation and value delivery at scale. Learning from organizations that have successfully transformed data into meaningful outcomes will position healthcare organizations to lead the future of healthcare innovation.
In conclusion, MDClone’s presence at HIMSS25 signifies a commitment to revolutionizing healthcare through data-driven insights and innovative technologies. By sharing success stories, presenting cutting-edge approaches, and offering valuable advice to attendees, MDClone is poised to make a significant impact on the healthcare industry.
